Sign in to NCBI
Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).

Lim YY, Jaeger J, Harrington K, Ashwood T, Ellis KA, Stöffler A, Szoeke C, Lachovitzki R, Martins RN, Villemagne VL, Bush A, Masters CL, Rowe CC, Ames D, Darby D, Maruff P.

Arch Clin Neuropsychol. 2013 Jun;28(4):320-30. doi: 10.1093/arclin/act021. Epub 2013 Apr 3.

PMID:
23552802
Free Article

Similar articles

2.

β-amyloid dynamics in human plasma.

Huang Y, Potter R, Sigurdson W, Kasten T, Connors R, Morris JC, Benzinger T, Mintun M, Ashwood T, Ferm M, Budd SL, Bateman RJ.

Arch Neurol. 2012 Dec;69(12):1591-7. doi: 10.1001/archneurol.2012.18107.

PMID:
23229043
Free PMC Article

Similar articles

3.

Improving Alzheimer's disease phase II clinical trials.

Greenberg BD, Carrillo MC, Ryan JM, Gold M, Gallagher K, Grundman M, Berman RM, Ashwood T, Siemers ER.

Alzheimers Dement. 2013 Jan;9(1):39-49. doi: 10.1016/j.jalz.2012.02.002. Epub 2012 Nov 16.

PMID:
23164548

Similar articles

4.

Rapid decline in episodic memory in healthy older adults with high amyloid-β.

Lim YY, Pietrzak RH, Ellis KA, Jaeger J, Harrington K, Ashwood T, Szoeke C, Martins RN, Bush AI, Masters CL, Rowe CC, Villemagne VL, Ames D, Darby D, Maruff P.

J Alzheimers Dis. 2013;33(3):675-9. doi: 10.3233/JAD-2012-121516.

PMID:
23001710

Similar articles

5.

Home time is extended in patients with ischemic stroke who receive thrombolytic therapy: a validation study of home time as an outcome measure.

Mishra NK, Shuaib A, Lyden P, Diener HC, Grotta J, Davis S, Davalos A, Ashwood T, Wasiewski W, Lees KR; Stroke Acute Ischemic NXY Treatment I Trialists.

Stroke. 2011 Apr;42(4):1046-50. doi: 10.1161/STROKEAHA.110.601302. Epub 2011 Feb 24.

PMID:
21350199

Similar articles

6.

Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study.

Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators.

J Alzheimers Dis. 2011;24(2):363-74. doi: 10.3233/JAD-2011-101554.

PMID:
21258153

Similar articles

7.

NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.

Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hårdemark HG, Rodichok L; SAINT I and II Investigators.

Stroke. 2008 Jun;39(6):1751-8. doi: 10.1161/STROKEAHA.107.503334. Epub 2008 Mar 27.

PMID:
18369171

Similar articles

8.

The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS).

Wahlgren NG, Bornhov S, Sharma A, Cederin B, Rosolacci T, Ashwood T, Claesson L; CLASS study group.

J Stroke Cerebrovasc Dis. 1999 Jul-Aug;8(4):231-9.

PMID:
17895170

Similar articles

9.

The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada.

Lyden PD, Ashwood T, Claesson L, Odergren T, Friday GH, Martin-Munley S.

J Stroke Cerebrovasc Dis. 1998 Nov-Dec;7(6):435-41.

PMID:
17895123

Similar articles

10.

NXY-059 for the treatment of acute ischemic stroke.

Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U; SAINT II Trial Investigators.

N Engl J Med. 2007 Aug 9;357(6):562-71.

PMID:
17687131
Free Article

Similar articles

11.

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.

Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, Grotta JC, Ashwood TJ, Hardemark HG, Svensson HH, Rodichok L, Wasiewski WW, Ahlberg G; CHANT Trial Investigators.

Stroke. 2007 Aug;38(8):2262-9. Epub 2007 Jun 14.

PMID:
17569876

Similar articles

12.

Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial.

Lees KR, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Ashwood T, Hardemark HG, Wasiewski W, Emeribe U, Zivin JA; SAINT I Investigators.

Stroke. 2006 Dec;37(12):2970-8. Epub 2006 Oct 26.

PMID:
17068304

Similar articles

13.

NXY-059 for acute ischemic stroke.

Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW; Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators.

N Engl J Med. 2006 Feb 9;354(6):588-600.

PMID:
16467546
Free Article

Similar articles

14.

Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.

Green AR, Lanbeck-Vallén K, Ashwood T, Lundquist S, Lindström Böö E, Jonasson H, Campbell M.

Brain Res. 2006 Feb 9;1072(1):224-6. Epub 2006 Jan 30.

PMID:
16448628

Similar articles

15.

Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.

Green AR, Ashwood T.

Curr Drug Targets CNS Neurol Disord. 2005 Apr;4(2):109-18. Review.

PMID:
15857295

Similar articles

16.

Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes.

Lyden P, Claesson L, Havstad S, Ashwood T, Lu M.

Arch Neurol. 2004 Nov;61(11):1677-80.

PMID:
15534178

Similar articles

17.

Early impairment in consciousness predicts mortality after hemispheric ischemic stroke.

Cucchiara BL, Kasner SE, Wolk DA, Lyden PD, Knappertz VA, Ashwood T, Odergren T, Nordlund A; CLASS-I Investigators.

Crit Care Med. 2004 Jan;32(1):241-5.

PMID:
14707586

Similar articles

18.

Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.

Green AR, Ashwood T, Odergren T, Jackson DM.

Pharmacol Ther. 2003 Dec;100(3):195-214. Review.

PMID:
14652110

Similar articles

19.

Animal models of stroke: do they have value for discovering neuroprotective agents?

Richard Green A, Odergren T, Ashwood T.

Trends Pharmacol Sci. 2003 Aug;24(8):402-8. Review.

PMID:
12915049

Similar articles

20.

Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients.

Zingmark PH, Ekblom M, Odergren T, Ashwood T, Lyden P, Karlsson MO, Jonsson EN.

Br J Clin Pharmacol. 2003 Aug;56(2):173-83.

PMID:
12895190
Free PMC Article

Similar articles

21.

Lack of hemispheric dominance for consciousness in acute ischaemic stroke.

Cucchiara B, Kasner SE, Wolk DA, Lyden PD, Knappertz VA, Ashwood T, Odergren T, Nordlund A.

J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):889-92.

PMID:
12810773
Free PMC Article

Similar articles

22.

Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results.

Lyden P, Shuaib A, Ng K, Levin K, Atkinson RP, Rajput A, Wechsler L, Ashwood T, Claesson L, Odergren T, Salazar-Grueso E; CLASS-I/H/T Investigators.

Stroke. 2002 Jan;33(1):122-8.

PMID:
11779900

Similar articles

23.

The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results.

Lyden P, Jacoby M, Schim J, Albers G, Mazzeo P, Ashwood T, Nordlund A, Odergren T.

Neurology. 2001 Oct 9;57(7):1199-205.

PMID:
11591835

Similar articles

24.

The clomethiazole acute stroke study (CLASS): Safety results in 1,356 patients with acute hemispheric stroke.

Wahlgren NG, Matias-Guiu J, Lainez JM, Veloso F, Ranasinha K, Grossman E, Ashwood T; CLASS Study Group.

J Stroke Cerebrovasc Dis. 2000 Jul-Aug;9(4):158-65. doi: 10.1053/jscd.2000.7236.

PMID:
24192021

Similar articles

25.

Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients.

Wahlgren NG, Díez-Tejedor E, Teitelbaum J, Arboix A, Leys D, Ashwood T, Grossman E.

Stroke. 2000 Jan;31(1):82-5.

PMID:
10625720

Similar articles

26.

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients.

Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PM, Ashwood T, Claesson L.

Stroke. 1999 Jan;30(1):21-8.

PMID:
9880383

Similar articles

27.

An open study of clomethiazole in patients with acute cerebral infarction.

Wester P, Strand T, Wahlgren NG, Ashwood T, Osswald G.

Cerebrovasc Dis. 1998 May-Jun;8(3):188-90. No abstract available.

PMID:
9619704

Similar articles

28.

Mercury in hair of muskrats (Ondatra zibethicus) and mink (Mustela vison) from the U. S. Department of Energy Oak Ridge Reservation.

Stevens RT, Ashwood TL, Sleeman JM.

Bull Environ Contam Toxicol. 1997 May;58(5):720-5. No abstract available.

PMID:
9115133

Similar articles

29.

An open study of remoxipride in the long-term treatment of schizophrenia-.

Ashwood TJ, Hallstrom C, King DJ, Livingston MG, McCreadie RG.

J Psychopharmacol. 1992 Jan;6(4):519-25. doi: 10.1177/026988119200600408.

PMID:
22291401

Similar articles

30.

A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients.

Tulloch JA, Ashwood TJ, Bateman DN, Woodhouse KW.

Age Ageing. 1991 Nov;20(6):424-9.

PMID:
1776591

Similar articles

31.

Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics.

Soni SD, Tench D, Ashwood TJ, Movin G.

Acta Psychiatr Scand Suppl. 1990;358:45-7.

PMID:
1978487

Similar articles

32.

Steady-state pharmacokinetics of controlled release and immediate release formulations of remoxipride in patients with chronic schizophrenia.

Tench D, Soni SD, Ashwood T, Movin G.

Psychopharmacology (Berl). 1990;101(1):132-6.

PMID:
1971445

Similar articles

33.

High school science education.

Stow SH, Ashwood TL.

Science. 1989 Nov 3;246(4930):563. No abstract available.

PMID:
2814479

Similar articles

34.

The expression of N-methyl-D-aspartate-receptor-mediated component during epileptiform synaptic activity in hippocampus.

Ashwood TJ, Wheal HV.

Br J Pharmacol. 1987 Aug;91(4):815-22.

PMID:
2889490
Free PMC Article

Similar articles

35.

Voltage-clamp analysis of somatic gamma-aminobutyric acid responses in adult rat hippocampal CA1 neurones in vitro.

Ashwood TJ, Collingridge GL, Herron CE, Wheal HV.

J Physiol. 1987 Mar;384:27-37.

PMID:
3656147
Free PMC Article

Similar articles

36.

Extracellular studies on the role of N-methyl-D-aspartate receptors in epileptiform activity recorded from the kainic acid-lesioned hippocampus.

Ashwood TJ, Wheal HV.

Neurosci Lett. 1986 Jun 18;67(2):147-52.

PMID:
2873533

Similar articles

37.

Loss of inhibition in the CA1 region of the kainic acid lesioned hippocampus is not associated with changes in postsynaptic responses to GABA.

Ashwood TJ, Wheal HV.

Brain Res. 1986 Mar 5;367(1-2):390-4.

PMID:
3008925

Similar articles

38.

Intracellular electrophysiology of CA1 pyramidal neurones in slices of the kainic acid lesioned hippocampus of the rat.

Ashwood TJ, Lancaster B, Wheal HV.

Exp Brain Res. 1986;62(1):189-98.

PMID:
3007192

Similar articles

39.

In vivo and in vitro studies on putative interneurones in the rat hippocampus: possible mediators of feed-forward inhibition.

Ashwood TJ, Lancaster B, Wheal HV.

Brain Res. 1984 Feb 20;293(2):279-91.

PMID:
6320970

Similar articles

Supplemental Content

Filters: Manage Filters

Loading ...
You are here: NCBI > Literature > PubMed
Support Center